AI Systems Analyst · Bespoke Mentis
AI systems analyst and governance specialist at Bespoke Mentis. Covers enterprise AI compliance, regulated industry strategy, and the operational decisions that determine whether AI deployments succeed or fail audit. Writes for CTOs, CISOs, and compliance officers who need evidence, not reassurance.
In April 2024, the U.S. Securities and Exchange Commission (SEC) publicly signaled that public companies should begin addressing artificial intelligence (AI) risks in their 2026 filings, despite the absence of a formal AI disclosure rule[1]. This directive, highlighted by the Harvard Law School Foru
The Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe have both been updated or interpreted in recent years to address the unique privacy and security challenges posed by artificial intelligence in healthcare,
Gartner reports that governance-first AI platforms are now a strategic imperative for regulated industries outside financial services, with healthcare, pharmaceuticals, and energy leading the adoption curve due to mounting regulatory scrutiny and the operational risks of opaque AI systems [1].
The introduction of generative AI and machine learning into cybersecurity has fundamentally altered the threat landscape, compelling Chief Information Security Officers (CISOs) to expand their roles beyond traditional risk management and technical oversight. In 2023, the National Institute of Standa
The International Energy Agency’s 2023 report on “AI Governance in Energy Systems” states unequivocally that the absence of comprehensive governance frameworks for AI in energy grids poses systemic risks to safety, reliability, and compliance, especially as AI-driven automation becomes foundational
The U.S. Treasury’s 2026 introduction of dedicated AI governance resources marks a pivotal shift in how financial institutions must approach AI risk management and compliance, with transparency and accountability now non-negotiable requirements [1].
The SEC’s 2026 public statement on artificial intelligence and emerging technologies underscores that, even in the absence of comprehensive AI-specific disclosure requirements, companies are expected to disclose all material risks—including those arising from AI systems—that could impact business op
On September 28, 2022, the U.S. Food and Drug Administration (FDA) issued its long-anticipated final guidance on Clinical Decision Support Software, clarifying how the agency will apply its risk-based approach to AI-driven healthcare tools and drawing a sharper line between regulated and unregulated
In 2026, the European Union’s Artificial Intelligence Act (AI Act) entered full enforcement, setting a global precedent for AI regulation, but leading organizations have already recognized that compliance alone is insufficient to address the deeper ethical challenges and trust deficits inherent in a
In 2023, the European Union’s Artificial Intelligence Act (AI Act) explicitly classified autonomous AI agents used in critical infrastructure and financial services as “high-risk” systems, mandating stringent governance, auditability, and human oversight requirements for any organization deploying s
The NIST AI Risk Management Framework (AI RMF) 2.0, released in January 2024, establishes a comprehensive, sector-agnostic approach for managing the risks associated with artificial intelligence while emphasizing trustworthiness, transparency, and accountability [1]. For regulated industries such as
On March 28, 2024, the U.S. Department of Health and Human Services (HHS) issued a directive requiring all cloud-based AI solutions handling protected health information (PHI) to operate exclusively on FedRAMP-authorized infrastructure, citing the need for uniform security controls and continuous mo
In 2023, the European Union’s AI Act explicitly assigned responsibility for AI risk management and compliance to senior executives, including CISOs, marking a regulatory shift that makes the CISO’s role in AI governance both explicit and non-negotiable[1]. This regulatory clarity reflects a broader
In 2021, the U.S. Food and Drug Administration (FDA) approved more than 130 AI-enabled medical devices, a record number that underscores the rapid integration of artificial intelligence into clinical workflows and the growing confidence in its capacity to enhance patient care while maintaining safet
On August 2, 2026, the European Union’s Artificial Intelligence Act (EU AI Act) entered into full force, marking the first comprehensive regulatory regime for AI anywhere in the world and imposing immediate, legally binding obligations on organizations deploying AI systems within the EU market [1].
The Federal Reserve’s 2026 update to SR 11-7 marks the first time the supervisory guidance explicitly expands its scope to include artificial intelligence (AI) and machine learning (ML) models, requiring banks to implement enhanced governance, validation, and risk controls for these technologies [1]
A 2023 World Economic Forum report identifies AI traceability frameworks as essential for ensuring accountability and building trust in AI systems, particularly in regulated sectors where the stakes of failure are high and the scrutiny is relentless [1].
The U.S. Food and Drug Administration’s (FDA) 21 CFR Part 11 mandates that all electronic records and signatures in healthcare software systems must be trustworthy, reliable, and equivalent to paper records, with comprehensive audit trails and traceability for every change—requirements that AI-drive
In November 2023, Forbes reported that AI-driven threat detection systems are transforming cybersecurity by reducing false positives and enabling faster, more accurate responses to cyber threats, thereby improving overall security posture[1]. This is not a theoretical promise—leading financial insti
In 2023, the U.S. Department of Health and Human Services (HHS) fined a major healthcare provider $1.25 million for failing to implement adequate technical safeguards in its AI-driven patient data systems, underscoring the real and immediate risks of noncompliant AI infrastructure in regulated secto
